Australia Markets open in 1 hr 4 mins

Medibio Limited (MEB.XA)

CXA - CXA Real-time price. Currency in AUD
Add to watchlist
0.00100.0000 (0.00%)
At close: 02:52PM AEDT

Medibio Limited

100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
61 3 9692 7222

Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Thomas R. Young M.D.Chief Exec. OfficerN/AN/AN/A
Ms. Renee Stanton-HorneOperations & Account Mang.N/AN/AN/A
Ms. Stephanie OttensInvestor Relations DirectorN/AN/AN/A
Mr. Josh PurdyPR DirectorN/AN/AN/A
Dr. Michael PlayerHead of ResearchN/AN/AN/A
Dr. Matthew FlaxHead of Algorithm Devel. TeamN/AN/AN/A
Mr. Archie Defillo M.D.Chief Medical OfficerN/AN/AN/A
Ms. Jennifer SolitarioSr. VP of Corp. HealthN/AN/AN/A
Mr. Massimiliano GrassiHead of Artificial IntelligenceN/AN/AN/A
Mr. Mathew Watkins C.A.Company Sec.N/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia.

Corporate governance

Medibio Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.